![](https://www.diabetesnews.com/wp-content/uploads/2013/04/pharma_pills-1-150x150.jpg)
If more insulin isn’t the answer to better control, what might be? Some researchers believe it might be dapagliflozin, a new drug that can prevent glucose reabsorption into the kidneys, lower A1c and reduce insulin doses simultaneously, according to a recently completed pilot Phase IIa trial.
Read more